Home

Kontraksjon Grunnleggende teori Nikke nmd pharma thomas hilm oppmerksomme Allergi suksess

Management team — NMD Pharma
Management team — NMD Pharma

NMD Pharma Initiates Combined Phase I/II Clinical trial — NMD Pharma
NMD Pharma Initiates Combined Phase I/II Clinical trial — NMD Pharma

NMD Pharma Raises €35 Million in a new Financing — NMD Pharma
NMD Pharma Raises €35 Million in a new Financing — NMD Pharma

Other news — NMD Pharma
Other news — NMD Pharma

Thomas Holm Pedersen (@NMDpharmaThomas) / Twitter
Thomas Holm Pedersen (@NMDpharmaThomas) / Twitter

NMD Pharma
NMD Pharma

Thomas Holm Pedersen (@NMDpharmaThomas) / Twitter
Thomas Holm Pedersen (@NMDpharmaThomas) / Twitter

NMD Pharma på LinkedIn: Vice President/Senior Director of Medicinal  Chemistry
NMD Pharma på LinkedIn: Vice President/Senior Director of Medicinal Chemistry

NMD Pharma på LinkedIn: Vice President/Senior Director of Medicinal  Chemistry
NMD Pharma på LinkedIn: Vice President/Senior Director of Medicinal Chemistry

NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth  — NMD Pharma
NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth — NMD Pharma

Management team — NMD Pharma
Management team — NMD Pharma

Management team — NMD Pharma
Management team — NMD Pharma

Founders — NMD Pharma
Founders — NMD Pharma

Other news — NMD Pharma
Other news — NMD Pharma

Other news — NMD Pharma
Other news — NMD Pharma

Other news — NMD Pharma
Other news — NMD Pharma

Founders — NMD Pharma
Founders — NMD Pharma

Other news — NMD Pharma
Other news — NMD Pharma

Other news — NMD Pharma
Other news — NMD Pharma

Other news — NMD Pharma
Other news — NMD Pharma

Management team — NMD Pharma
Management team — NMD Pharma

Other news — NMD Pharma
Other news — NMD Pharma

NMD Pharma treats first patient with the firm's most promising drug  candidate — MedWatch
NMD Pharma treats first patient with the firm's most promising drug candidate — MedWatch

Management team — NMD Pharma
Management team — NMD Pharma

Other news — NMD Pharma
Other news — NMD Pharma

Other news — NMD Pharma
Other news — NMD Pharma

Jeito Capital Becomes Key Investor in NMD Pharma as Part of a €35 Million  New Financing | Business Wire
Jeito Capital Becomes Key Investor in NMD Pharma as Part of a €35 Million New Financing | Business Wire

Other news — NMD Pharma
Other news — NMD Pharma

Other news — NMD Pharma
Other news — NMD Pharma